Spectranetics, a developer, manufacturer of medical devices used in minimally invasive procedures within the cardiovascular system, is set to unveil a new advanced peripheral atherectomy simulation system to remove peripheral arterial occlusions in both above the knee and below the knee.
Spectranetics has once again partnered with Medical Simulation Corporation (MSC) to develop the Laser Atherectomy Simulator in conjunction with MSC’s SimSuite simulation technology platform.
The new simulation system features simulated patient scenarios that allow physicians to manipulate lesion crossing and ablating tools with tactile feedback and visual diagnostics such as virtual x-ray and IVUS imagery.
The simulation system incorporates use of the Spectranetics QuickCross Crossing Catheters, Turbo Elite peripheral laser ablation catheter, and the Turbo Tandem peripheral laser ablation catheter designed for larger vessels.
Spectranetics Marketing and Business Development Sales senior vice president Jason Hein said the peripheral vascular excimer laser simulation system provides physicians with tools to assist them in achieving safe and effective patient outcomes.